Benign Prostatic Hyperplasia
Apr 22, 2008
AEterna Zentaris' Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia
“We are pleased that Spectrum is proceeding with plans for their upcoming study”
QUEBEC CITY, April 22 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. , a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its partner, Spectrum Pharmaceuticals , ... via Earth Times
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| BioXell announces positive Phase IIb results fo... (from Nov '07) | Nov '07 | ELO | 2 |
| BPH - Post Surgery Problems (from Dec '06) | Dec '06 | Sweta | 1 |
| Adding Flomax Or Hytrin To Viagra Does Not Indu... (from Apr '06) | Apr '06 | ras | 1 |
| Protect Your Prostate | Mar '06 | W Mullins | 1 |
| Doxazosin Plus Finasteride Reduced Clinical Pro... | Feb '06 | nermeen | 1 |
Most Popular
